Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for Q15853

Entry ID Method Resolution Chain Position Source
8IA3 X-ray 350 A A/B/E/F 235-346 PDB
AF-Q15853-F1 Predicted AlphaFoldDB

268 variants for Q15853

Variant ID(s) Position Change Description Diseaes Association Provenance
RCV000149149
CA174452
COSM1179634
rs193920819
166 R>Q Malignant tumor of prostate prostate [ClinVar, Cosmic] Yes ClinGen
cosmic curated
ClinVar
Ensembl
dbSNP
rs1599618064
CA405292736
2 D>A No ClinGen
Ensembl
rs979598371
CA307723844
3 M>I No ClinGen
Ensembl
rs777702044
CA9375265
3 M>T No ClinGen
ExAC
gnomAD
rs1481979690
CA405292776
5 D>A No ClinGen
gnomAD
CA405292772
rs1236601406
5 D>H No ClinGen
TOPMed
gnomAD
CA405292790
rs1411983823
6 P>S No ClinGen
TOPMed
CA405292804
rs1173022597
7 G>A No ClinGen
TOPMed
rs1173022597
CA405292803
7 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA405292812
rs1379260920
8 L>Q No ClinGen
TOPMed
CA405292809
rs1599618148
8 L>V No ClinGen
Ensembl
CA405292838
rs1176760655
10 P>L No ClinGen
TOPMed
rs1290368087
CA405292844
11 A>T No ClinGen
gnomAD
CA405292862
rs1178730024
12 A>D No ClinGen
TOPMed
CA405292859
rs1200142261
12 A>T No ClinGen
TOPMed
gnomAD
rs1256391454
CA405292873
13 S>L No ClinGen
TOPMed
rs1276800999
CA405292868
13 S>P No ClinGen
gnomAD
CA405292877
rs1443891651
14 A>T No ClinGen
gnomAD
rs1208043625
CA405292885
14 A>V No ClinGen
TOPMed
CA405292891
rs1349471682
15 T>S No ClinGen
TOPMed
rs1211340845
CA405292899
16 A>T No ClinGen
gnomAD
rs1024571866
CA307723848
16 A>V No ClinGen
TOPMed
gnomAD
rs970367311
CA307723869
19 A>T No ClinGen
TOPMed
gnomAD
CA405292951
rs1312531700
20 A>G No ClinGen
TOPMed
rs1363917693
CA405292948
20 A>S No ClinGen
TOPMed
gnomAD
rs1363917693
CA405292944
20 A>T No ClinGen
TOPMed
gnomAD
rs1412984485
CA405292962
21 S>N No ClinGen
TOPMed
CA9375280
rs778571672
22 H>Q No ClinGen
ExAC
TOPMed
gnomAD
CA9375279
rs754612332
22 H>Y No ClinGen
ExAC
gnomAD
CA405293028
rs1291617505
23 D>G No ClinGen
TOPMed
rs868455019
CA307723997
23 D>Y No ClinGen
Ensembl
CA405293046
rs1355629120
24 K>N No ClinGen
gnomAD
rs752152401
CA9375281
24 K>R No ClinGen
ExAC
TOPMed
gnomAD
CA307724000
rs752152401
24 K>T No ClinGen
ExAC
TOPMed
gnomAD
CA307724008
rs777135887
25 G>E No ClinGen
ExAC
TOPMed
gnomAD
CA9375282
rs757994644
25 G>R No ClinGen
ExAC
gnomAD
rs777135887
CA9375283
25 G>V No ClinGen
ExAC
TOPMed
gnomAD
rs1468628205
CA405293062
26 P>S No ClinGen
TOPMed
gnomAD
rs1245850553
CA405293078
27 E>D No ClinGen
gnomAD
CA9375284
rs374238178
28 A>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs200773644
CA9375285
29 E>D No ClinGen
ExAC
TOPMed
gnomAD
rs1457900753
CA405293126
31 G>D No ClinGen
gnomAD
CA405293120
rs1234088151
31 G>S No ClinGen
gnomAD
rs781164536
CA405293132
32 V>I No ClinGen
ExAC
gnomAD
rs781164536
CA9375286
32 V>L No ClinGen
ExAC
gnomAD
CA405293139
rs1348320084
33 E>K No ClinGen
TOPMed
rs1462048055
CA405293158
36 E>K No ClinGen
gnomAD
CA9375319
rs751127602
37 G>D No ClinGen
ExAC
TOPMed
gnomAD
rs767127112
CA9375321
39 D>G No ClinGen
ExAC
gnomAD
CA307724124
rs916659768
40 G>D No ClinGen
TOPMed
CA405293197
rs1282966542
40 G>R No ClinGen
gnomAD
CA405293202
rs1306446947
COSM1524749
41 P>A lung Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
rs750430636
CA9375322
43 A>T No ClinGen
ExAC
gnomAD
TCGA novel 44 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA405293218
rs1411717303
44 E>K No ClinGen
TOPMed
CA9375323
rs755980897
45 E>D No ClinGen
ExAC
TOPMed
gnomAD
CA405293242
rs1302189707
47 T>A No ClinGen
TOPMed
CA405293246
rs1436394439
47 T>R No ClinGen
gnomAD
CA405293247
rs1177872293
48 A>T No ClinGen
gnomAD
rs779933707
COSM1231908
CA9375324
48 A>V large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs1175246327
CA405293262
50 A>V No ClinGen
TOPMed
gnomAD
rs867189214
CA307724139
54 V>A No ClinGen
Ensembl
CA9375329
rs771058625
62 H>D No ClinGen
ExAC
TOPMed
gnomAD
CA405293343
rs1303724217
62 H>R No ClinGen
gnomAD
CA405293340
rs771058625
62 H>Y No ClinGen
ExAC
TOPMed
gnomAD
rs1228133537
CA405293347
63 N>H No ClinGen
gnomAD
CA9375331
rs746426240
64 I>V No ClinGen
ExAC
gnomAD
CA405293378
rs981896212
67 Q>* No ClinGen
TOPMed
gnomAD
rs981896212
CA307724143
67 Q>E No ClinGen
TOPMed
gnomAD
rs770157891
COSM994919
CA9375332
69 R>C Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA405293394
rs1195676112
69 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA405293412
rs1421554401
72 T>A No ClinGen
gnomAD
rs774209183
CA9375336
73 N>K No ClinGen
ExAC
gnomAD
CA405293424
rs1163422090
74 G>R No ClinGen
gnomAD
rs761542150
CA9375337
75 G>E No ClinGen
ExAC
TOPMed
gnomAD
rs1284603030
CA405293430
75 G>R No ClinGen
TOPMed
gnomAD
rs1326084966
CA405293436
76 Q>E No ClinGen
gnomAD
rs1482533972
CA405293439
76 Q>R No ClinGen
TOPMed
rs1183366311
CA405293483
81 V>L No ClinGen
gnomAD
CA405293493
rs1233082179
83 Q>K No ClinGen
gnomAD
rs1599620672
CA405293503
84 V>L No ClinGen
Ensembl
CA405293520
rs1246753337
86 D>E No ClinGen
TOPMed
CA405293514
rs1599620681
86 D>H No ClinGen
Ensembl
rs1477529917
CA405293521
87 G>S No ClinGen
TOPMed
gnomAD
rs1599620704
CA405293534
88 Q>H No ClinGen
Ensembl
TCGA novel 88 Q>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1393708738
CA405293530
88 Q>P No ClinGen
gnomAD
rs749804522
CA405293536
89 L>V No ClinGen
ExAC
TOPMed
gnomAD
CA405293548
rs1174743813
91 G>C No ClinGen
TOPMed
gnomAD
rs1331054477
CA405293585
96 A>D No ClinGen
gnomAD
CA307724342
rs543449268
97 G>S No ClinGen
1000Genomes
TOPMed
gnomAD
CA307724345
rs1036598552
98 A>T No ClinGen
TOPMed
gnomAD
rs1299781845
CA405293596
98 A>V No ClinGen
TOPMed
CA405293602
rs1330360660
99 V>A No ClinGen
TOPMed
rs1005489302
CA307724348
104 T>S No ClinGen
TOPMed
CA405293639
rs1356503392
105 A>G No ClinGen
TOPMed
gnomAD
CA307724352
rs1023619519
105 A>S No ClinGen
TOPMed
gnomAD
CA307724355
rs969415814
106 A>T No ClinGen
TOPMed
gnomAD
CA405293651
rs1197031194
107 F>L No ClinGen
gnomAD
rs1450662692
CA405293669
110 G>V No ClinGen
TOPMed
gnomAD
CA405293691
rs1191306963
113 A>G No ClinGen
gnomAD
rs1453490160
CA405293688
113 A>P No ClinGen
TOPMed
CA9375357
rs771804118
114 V>A No ClinGen
ExAC
gnomAD
rs1269906132
CA405293698
115 T>P No ClinGen
TOPMed
rs994925567
CA405293719
118 G>C No ClinGen
TOPMed
rs994925567
CA307724359
118 G>S No ClinGen
TOPMed
rs1276672956
CA405293726
119 V>A No ClinGen
TOPMed
rs1027383711
CA307724363
119 V>M No ClinGen
gnomAD
rs1344224353
CA405293751
123 A>S No ClinGen
TOPMed
CA405293754
rs1272802948
123 A>V No ClinGen
TOPMed
rs111781333
CA307724366
124 Q>E No ClinGen
Ensembl
rs1194718968
CA405293765
125 R>H No ClinGen
TOPMed
gnomAD
CA307724369
rs995847619
127 G>A No ClinGen
gnomAD
rs995847619
CA405293777
127 G>V No ClinGen
gnomAD
rs927779764
CA307724380
128 P>S No ClinGen
TOPMed
rs1599621027
CA405293784
129 A>T No ClinGen
Ensembl
CA405293791
rs1371936328
130 A>S No ClinGen
TOPMed
rs1169706409
CA405293808
133 V>M No ClinGen
gnomAD
rs1410959742
CA405293819
134 P>L No ClinGen
TOPMed
CA9375359
rs555503800
135 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs142459461
CA307724910
145 V>M No ClinGen
ESP
TOPMed
gnomAD
CA9375399
rs769726179
147 Q>H No ClinGen
ExAC
gnomAD
CA9375400
rs775471907
149 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
COSM1641126
CA405294047
rs1394201893
151 S>N stomach [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
rs368496403
CA9375402
151 S>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA405294055
rs1184627505
152 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1464690381
CA405294084
156 P>L No ClinGen
TOPMed
CA405294082
rs1464690381
156 P>Q No ClinGen
TOPMed
rs892470977
CA307724939
157 A>P No ClinGen
TOPMed
gnomAD
rs892470977
CA405294085
157 A>T No ClinGen
TOPMed
gnomAD
CA405294088
rs1207048850
157 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA405294096
rs1361550595
159 E>K No ClinGen
TOPMed
CA9375407
rs755179671
160 A>D No ClinGen
ExAC
gnomAD
CA9375406
rs748740602
160 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA405294120
rs1370663080
162 S>R No ClinGen
gnomAD
CA9375408
rs765398782
163 G>R No ClinGen
ExAC
gnomAD
CA405294127
rs1283016548
164 E>K No ClinGen
gnomAD
rs372626837
CA9375410
165 A>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs372626837
CA9375409
165 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1203870304
CA405294144
167 F>L No ClinGen
gnomAD
rs1382494953
CA405294151
168 A>T No ClinGen
TOPMed
TCGA novel 168 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1389541521
CA405294161
169 Y>C No ClinGen
TOPMed
TCGA novel 171 P>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs143950345
CA9375411
171 P>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs747352642
CA307725006
172 A>S No ClinGen
ExAC
gnomAD
rs747352642
CA9375412
172 A>T No ClinGen
ExAC
gnomAD
CA405294181
rs1425963674
172 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA307725010
rs1040069298
173 S>P No ClinGen
TOPMed
gnomAD
rs780754922
CA9375414
174 S>G No ClinGen
ExAC
gnomAD
rs745514041
CA9375415
176 G>E No ClinGen
ExAC
gnomAD
CA9375418
rs749219730
178 T>N No ClinGen
ExAC
TOPMed
gnomAD
CA9375417
rs774955846
178 T>S No ClinGen
ExAC
gnomAD
CA9375419
rs768595636
179 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA405294219
rs774035837
179 T>K No ClinGen
ExAC
gnomAD
CA9375420
rs774035837
179 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1324723134
CA405294223
180 A>S No ClinGen
gnomAD
CA9375422
rs377120409
181 V>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs28365138
CA307725069
183 V>G No ClinGen
Ensembl
CA9375424
rs759815013
183 V>I No ClinGen
ExAC
gnomAD
CA405294254
rs1214446211
185 T>S No ClinGen
gnomAD
CA9375426
rs373379664
186 T>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA405294292
rs1272772703
191 Q>K No ClinGen
gnomAD
CA9375428
rs764602073
192 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs1353598373
CA405294334
195 Q>R No ClinGen
gnomAD
CA9375460
rs746745001
196 F>Y No ClinGen
ExAC
gnomAD
CA9375462
rs775846053
198 V>I No ClinGen
ExAC
gnomAD
CA405294364
rs1471108642
199 M>I No ClinGen
TOPMed
CA9375463
rs763069146
200 M>V No ClinGen
ExAC
gnomAD
CA9375466
rs762338414
204 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs1182351067
CA405294408
206 L>V No ClinGen
TOPMed
CA9375468
rs563307201
207 Q>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA405294432
rs1231302409
209 G>E No ClinGen
TOPMed
gnomAD
CA9375470
rs766640758
211 Q>P No ClinGen
ExAC
gnomAD
CA9375471
rs753576519
213 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs752209084
CA9375475
216 P>R No ClinGen
ExAC
gnomAD
rs201560339
CA9375477
217 R>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs769279094 217 R>P Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA9375476
rs201560339
217 R>W No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA405294480
rs1335009480
218 T>A No ClinGen
gnomAD
rs139781881
CA9375478
220 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1440232153
CA405294495
220 P>S No ClinGen
gnomAD
CA405294511
rs1233314713
222 S>F No ClinGen
gnomAD
CA405294513
rs1278088095
223 P>A No ClinGen
gnomAD
CA9375479
COSM565460
rs757173577
223 P>L lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs1181075910
CA405294593
225 I>M No ClinGen
gnomAD
CA307725605
rs1047533275
226 D>G No ClinGen
TOPMed
gnomAD
CA405294620
rs1185975968
227 G>V No ClinGen
gnomAD
CA307725608
rs929262031
228 T>N No ClinGen
gnomAD
TCGA novel 229 R>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs757343192
CA9375548
229 R>T No ClinGen
ExAC
gnomAD
rs529219305
CA307725617
230 T>S No ClinGen
Ensembl
rs887814129
CA307725621
231 P>S No ClinGen
TOPMed
rs140499717
CA405294669
232 R>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA405294672
rs1218000182
232 R>Q No ClinGen
TOPMed
rs1374835641
CA405294689
233 D>E No ClinGen
gnomAD
rs1568457576
CA405294709
235 R>G No ClinGen
Ensembl
rs1432320211
CA405294712
235 R>K No ClinGen
gnomAD
CA9375552
rs780583886
237 R>K No ClinGen
ExAC
TOPMed
gnomAD
CA9375553
rs749605548
238 A>T No ClinGen
ExAC
gnomAD
CA405294757
rs1315462178
240 H>R No ClinGen
TOPMed
CA405294769
rs1347878390
242 E>K No ClinGen
gnomAD
rs1320119248
CA405295771
260 K>N No ClinGen
gnomAD
rs779170568
CA9375595
264 D>E No ClinGen
ExAC
TOPMed
gnomAD
CA307732824
rs368595372
267 A>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA9375597
rs368595372
267 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs746655773
CA9375598
268 D>A No ClinGen
ExAC
TOPMed
gnomAD
CA307732836
rs868523437
268 D>E No ClinGen
Ensembl
rs746655773
CA307732827
268 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs1247213268
CA405295853
272 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA9375600
rs780652712
273 G>A No ClinGen
ExAC
gnomAD
rs770480113
CA9375599
273 G>R No ClinGen
ExAC
gnomAD
rs1477880598
CA405295859
274 A>T No ClinGen
gnomAD
rs745834456
CA9375601
274 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs1193802654
CA405296341
282 K>E No ClinGen
TOPMed
rs753231177
CA9375664
288 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA405296430
rs1173274317
289 E>Q No ClinGen
gnomAD
CA405296448
rs1599636279
291 R>C No ClinGen
Ensembl
CA9375666
rs779062840
291 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs540944210
CA307733198
294 N>K No ClinGen
Ensembl
CA9375667
rs748085813
294 N>S No ClinGen
ExAC
gnomAD
rs1014141298
CA307733204
296 R>H No ClinGen
TOPMed
gnomAD
rs200122252
CA307733205
303 E>K No ClinGen
1000Genomes
CA307733223
rs1014868247
305 E>A No ClinGen
gnomAD
rs1269133583
CA405296619
305 E>D No ClinGen
gnomAD
rs1014868247
CA405296616
305 E>G No ClinGen
gnomAD
CA405296610
rs1332824568
305 E>K No ClinGen
TOPMed
gnomAD
CA9375671
rs769863714
306 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs201285877
CA307733255
308 Q>P No ClinGen
Ensembl
CA405296679
rs1568462861
310 D>E No ClinGen
Ensembl
TCGA novel 310 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA307733259
rs1047177800
310 D>N No ClinGen
TOPMed
CA9375672
rs775649817
311 N>H No ClinGen
ExAC
TOPMed
gnomAD
CA405296712
rs1200226653
312 E>D No ClinGen
TOPMed
gnomAD
rs1453885021
CA405296698
312 E>K No ClinGen
gnomAD
TCGA novel 314 L>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs865961504
CA307733267
315 R>G No ClinGen
Ensembl
rs369650457
CA9375704
318 I>= Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA9375703
rs369650457
318 I>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA9375702
rs763001272
318 I>V No ClinGen
ExAC
gnomAD
rs757056187
CA9375705
319 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA405297051
rs757056187
319 E>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1478059671
CA405297068
320 E>G No ClinGen
TOPMed
TCGA novel 320 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA405297096
rs1378372973
323 N>D No ClinGen
gnomAD
CA405297101
rs1441411270
323 N>K No ClinGen
gnomAD
rs968843676
CA307733450
325 N>S No ClinGen
TOPMed
gnomAD
CA9375707
rs376281522
COSM1240614
326 A>T oesophagus [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
CA405297135
rs1304206013
326 A>V No ClinGen
gnomAD
rs1402548300
CA405297138
327 L>M No ClinGen
gnomAD
CA405297147
rs1453792547
328 L>F No ClinGen
gnomAD
TCGA novel 329 R>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA9375708
rs755152354
329 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA405297158
rs755152354
329 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs369112998
CA307733474
330 A>T No ClinGen
ESP
TOPMed
gnomAD
rs1311622996
CA405297196
333 Q>* No ClinGen
gnomAD
CA9375710
rs748160229
333 Q>P No ClinGen
ExAC
TOPMed
gnomAD
rs1257979896
CA405297208
334 Q>R No ClinGen
gnomAD
rs772188137
CA9375711
335 H>Y No ClinGen
ExAC
gnomAD
rs373384211
CA9375712
336 N>D No ClinGen
ESP
ExAC
gnomAD
rs747530101
CA9375713
339 M>T No ClinGen
ExAC
gnomAD
rs1348617381
CA405297289
341 G>D No ClinGen
TOPMed
CA405297286
rs1179113977
341 G>R No ClinGen
gnomAD
CA307733509
rs976745887
342 E>K No ClinGen
TOPMed
CA405297306
rs1177649600
343 G>S No ClinGen
gnomAD
rs975615949
CA307733511
344 T>P No ClinGen
Ensembl
CA307733517
rs922587314
345 R>Q No ClinGen
TOPMed
gnomAD
CA405297334
rs1244798550
346 Q>P No ClinGen
gnomAD

No associated diseases with Q15853

1 regional properties for Q15853

Type Name Position InterPro Accession
domain Myc-type, basic helix-loop-helix (bHLH) domain 235 - 296 IPR011598

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
chromatin The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
intracellular membrane-bounded organelle Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

8 GO annotations of molecular function

Name Definition
bHLH transcription factor binding Binding to a basic Helix-Loop-Helix (bHLH) superfamily of transcription factors, important regulatory components in transcriptional networks of many developmental pathways.
DNA-binding transcription factor activity A transcription regulator activity that modulates transcription of gene sets via selective and non-covalent binding to a specific double-stranded genomic DNA sequence (sometimes referred to as a motif) within a cis-regulatory region. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
DNA-binding transcription factor activity, RNA polymerase II-specific A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II.
protein heterodimerization activity Binding to a nonidentical protein to form a heterodimer.
protein homodimerization activity Binding to an identical protein to form a homodimer.
RNA polymerase II cis-regulatory region sequence-specific DNA binding Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II.
sequence-specific DNA binding Binding to DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
sequence-specific double-stranded DNA binding Binding to double-stranded DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA, e.g. promotor binding or rDNA binding.

7 GO annotations of biological process

Name Definition
lactation The regulated release of milk from the mammary glands and the period of time that a mother lactates to feed her young.
late viral transcription The transcription of the final group of viral genes of the viral life cycle, following middle transcription, or where middle transcription doesn't occur, following early transcription. Involves the transcription of genes encoding structural proteins.
lipid homeostasis Any process involved in the maintenance of an internal steady state of lipid within an organism or cell.
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
positive regulation of transcription from RNA polymerase II promoter by glucose Any process involving glucose that activates or increases the rate of transcription from an RNA polymerase II promoter.
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
regulation of transcription from RNA polymerase II promoter by glucose Any process involving glucose that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter.

3 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P19484 TFEB Transcription factor EB Homo sapiens (Human) PR
Q9R210 Tfeb Transcription factor EB Mus musculus (Mouse) PR
Q08874 Mitf Microphthalmia-associated transcription factor Mus musculus (Mouse) PR
10 20 30 40 50 60
MDMLDPGLDP AASATAAAAA SHDKGPEAEE GVELQEGGDG PGAEEQTAVA ITSVQQAAFG
70 80 90 100 110 120
DHNIQYQFRT ETNGGQVTYR VVQVTDGQLD GQGDTAGAVS VVSTAAFAGG QQAVTQVGVD
130 140 150 160 170 180
GAAQRPGPAA ASVPPGPAAP FPLAVIQNPF SNGGSPAAEA VSGEARFAYF PASSVGDTTA
190 200 210 220 230 240
VSVQTTDQSL QAGGQFYVMM TPQDVLQTGT QRTIAPRTHP YSPKIDGTRT PRDERRRAQH
250 260 270 280 290 300
NEVERRRRDK INNWIVQLSK IIPDCNADNS KTGASKGGIL SKACDYIREL RQTNQRMQET
310 320 330 340
FKEAERLQMD NELLRQQIEE LKNENALLRA QLQQHNLEMV GEGTRQ